The prefrontal cortex (PFC) ventral to the genu of the corpus callosum has been implicated in the modulation of visceral responses to stressful and emotionally provocative stimuli, based upon analysis of lesion effects involving this area in humans and experimental animals. In a recent magnetic resonance imaging (MRI) study of familial mood disorders, we demonstrated that the mean grey matter volume of this cortex is abnormally reduced in subjects with major depressive disorder (MDD) and bipolar disorder, irrespective of their treatment status or current mood state. Moreover, in preliminary histopathological assessments of subgenual PFC tissue taken post mortem from subjects with MDD and bipolar disorder we obtained results suggesting that this decrement in grey matter volume is associated with a reduction in glia without an equivalent loss of neurons. The potential functional significance of these neuroimaging and microscopic abnormalities is discussed with respect to evidence that subgenual PFC dysfunction may disturb stress-related autonomic and neuroendocrine responses and reward-related mesolimbic dopamine function. These data may thus hold important implications for the development of neural models of mood disorders that can account for the abnormal hedonic, motivational, neuroendocrine, and autonomic manifestations evident in these idiopathic conditions. Keywords: anterior cingulate; glia; MRI; PET; major depression; bipolar disorder; emotion
In a recent neuroimaging study of mood disorders we reported that the grey matter volume of the prefrontal cortex (PFC) ventral to the genu of the corpus callosum is reduced in familial bipolar disorder and familial major depressive disorder (MDD). 1 The magnetic resonance imaging (MRI)-based neuromorphometric measures acquired to demonstrate this abnormality in the 'subgenual' PFC were guided by positron emission tomographic (PET) images that showed an abnormal reduction of cerebral blood flow (BF) and glucose metabolism in this area in depression. [2] [3] [4] Because antidepressant treatment did not reverse these physiological abnormalities, the MRI measures of grey matter volume were obtained to determine whether the decrements in regional BF and metabolism were at least partly explained by a corresponding reduction in cortex. 5 This hypothesis was confirmed, as the mean grey matter volume of the left subgenual PFC was reduced by 39% and 48% in the bipolar disordered and unipolar depressed samples, respectively, relative to the controls (F = 9.8; P Ͻ 0.0002, after covarying for age, gender and whole brain volume). 1 This volumetric 1 In pursuing the nature of these neuroimaging abnormalities, D Ö ngü r and JL Price initiated post mortem histopathological assessments of brain tissue taken from the left subgenual PFC of subjects who had been clinically diagnosed as having bipolar disorder, MDD, or no psychiatric disorder (courtesy of the Harvard Brain Bank and the Washington University Department of Pathology). The neuroimaging data had specifically implicated the cortex situated on the anterior cingulate gyrus ventral to the anteroventral border of the corpus callosum, which in the human is comprised predominantly of area 24b and, to a lesser extent, 24a ( Figure  1 ; in contrast, in the Macaque area 24b is situated anterior to the genu of the corpus callosum). 1, 6 The initial histopathological assessments thus targeted the section of area 24a and 24b (microscopically defined by its agranularity) located ventral and caudal to the genu of the corpus callosum ( Figure 2 ).
Preliminary post mortem measures from four subjects with a history of MDD, three with bipolar disorder and four with no history of psychiatric disorders were consistent with a reduction in the mean grey matter volume of the subgenual PFC in both mood-disordered groups (Figure 2) . Cell counting studies suggested that The subgenual PFC consists of agranular cortex on the anterior cingulate gyrus ventral to the genu of the corpus callosum. 1, 6 Modified from Drevets et al.
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Figure 2
Post mortem measures of grey matter volume (left ordinate) and absolute cell number (right ordinate) obtained from the left subgenual PFC in controls (n = 4), unipolar depressives (n = 4), and bipolar disordered subjects (n = 3). The subject groups did not significantly differ in mean age, post mortem interval, or gender composition. The mean duration of formaldehyde fixation was longer for the mood-disordered subjects than for the controls, although this would not be expected to selectively alter glial counts or profiles in Nissl-stained tissue. The subgenual PFC measures were obtained from area 24, as defined in Nissl-stained tissue as the agranular cortex dorsal to granular area 10 ( Figure 1 ), 6 in evenly spaced coronal sections spanning from the slice immediately caudal to the genu of the corpus callosum through the slice 8 mm caudal to the genu. Area 24 comprised most of the first full gyrus ventral to the anteroventral border of the corpus callosum ( Figure 1 ; the MRIbased neuromorphometric measures discussed in the text were acquired by segmenting the grey matter on this gyrus 1 ). The cortical volume of area 24 was measured using stereological techniques (Cavalieri estimator) and the cell number and density were measured using an optical dissector. Both the absolute glial number and the glial density were reduced (P Ͻ 0.05) in the combined mood disorder group relative to the control group. the decrement in grey matter is associated with a reduction in glia without an equivalent loss of neurons. The glial cell counts of six of the seven mood-disordered subjects were less than the mean glial count of the controls, and three mood-disordered subjects had dramatically reduced glial numbers, with cell counts of only 3%, 13%, and 24% (in one bipolar and two unipolar subjects, respectively) of the mean value of the controls. In contrast, the neuronal number was not decreased and the neuronal density appeared increased, as would be expected in association with a reduction in cortical volume (five of the seven mooddisordered subjects had neuronal densities which exceeded the upper range of neuronal density in the controls).
Consistent with the expectation that mood disorders are heterogenous with respect to etiology, 7 the variability of these glial counts and of our previous MRI measures in the subgenual PFC are high across mooddisordered subjects and the ranges of values in the ill and normative groups partly overlap. Such variability is typical of psychobiological data acquired from mood-disordered samples, which generally show that subsets, rather than entire samples, of subjects meeting criteria for MDD and bipolar disorder manifest biological markers for affective disease. 7 In our neuroimaging study, we enhanced the likelihood of identifying biological markers by selecting subjects who had firstdegree relatives with the same mood disorder diagnosis. 1, 7, 8 The extent to which the neuroimaging abnormalities in the subgenual PFC also extend to non-fam-ilial cases thus remains unclear. Nevertheless, in contrast to depressive samples with familial pure depressive disease or familial bipolar disorder, who both showed abnormally reduced metabolism in this area, we observed that subjects who met criteria for depression spectrum disease (MDD subjects with firstdegree relatives who have alcoholism or sociopathy, and not mania), 8 did not significantly differ from controls with respect to the mean subgenual PFC glucose metabolism. 9 Moreover, a recent MRI study found that the mean subgenual PFC grey matter volume (defined using the anatomical landmarks we used 1 ) was significantly reduced with respect to controls in bipolar subjects with mood-disordered first-degree relatives (consistent with our data 1 ), but not in bipolar subjects without mood-disordered first-degree relatives (Y Hirayasu, personal communication). Post mortem studies of subjects with well-characterized personal and family history will ultimately be needed to establish whether the histopathological changes in the subgenual PFC are specific to familial subtypes of mood disorders.
While these microscopic findings require confirmation in larger subject samples, characterization by specific stains, and replication across laboratories, their potential impact upon elucidating the pathophysiology of familial mood disorders may be substantial. In contrast to the nonspecific glial proliferation seen in neurodegenerative disorders, reductions in glia have generally not been reported in other conditions. It is nevertheless critical to establish that reductions in glial numbers are not simply associated with nonspecific factors such as exposure to psychotropic drugs or alcohol. If such changes prove specific to mood disorders, determining whether they reflect a neurodevelopmental defect (eg, associated with genetic factors regulating glial genesis or proliferation) or an acquired effect of recurrent illness may provide clues regarding the etiology of familial mood disorders.
Future studies must also characterize the anatomical specificity of these microscopic changes. In our neuroimaging study, we did not identify significant differences between the bipolar and control groups in the volume of other portions of the anterior cingulate cortex or of the whole brain.
1 Nevertheless, the methods we employed were insensitive to potential, regional anatomical differences in other structures. We thus selected the less specific term 'subgenual PFC' in lieu of more specific designations (eg, 'subcallosal anterior cingulate') to reflect the uncertainty involved in defining the anatomical extent of an abnormality using neuroimaging techniques. The preliminary microscopic assessments of the subgenual PFC tissue described above may justify this approach, since the reduction in glia appears to also extend ventrally beyond area 24 into the remainder of the ventromedial prefrontal cortical wall.
Comparison with other structural neuroimaging studies
While previous MRI and post mortem studies of mood disorders have not specifically examined the subgenual PFC, neuromorphometric abnormalities have been reported in structures that are anatomically related to the subgenual PFC. 10 In an MRI-based morphometric study of bipolar disorder, Pearlson et al 11 found that of several temporal lobe structures examined, only the left amygdala was abnormally reduced in volume. Since the amygdala and the subgenual PFC share substantial, predominantly ipsilateral anatomical connections, it is possible that the left-lateralized volumetric reductions in these two structures are related. 12 The caudate nucleus has also been found to be abnormally reduced in volume in MDD, although this finding was not replicated in bipolar disorder. 10, 13 The subgenual PFC and the amygdala specifically project to the 'limbic' striatum, comprised of the ventromedial caudate and the nucleus accumbens. 12 Post mortem studies that more specifically examine these striatal areas may thus have greater sensitivity for identifying histopathological changes common to both MDD and bipolar disorder.
Finally, third ventricle enlargement is consistently found in studies of bipolar disorder, although the specific tissue where volume loss resulted in ex vaccuo changes in third ventricle size has remained unclear. 10, 11 The subgenual PFC shares extensive reciprocal connections with the periventricular and mediodorsal nuclei of the thalamus that line the third ventricle wall. 12 Post mortem assessments of these nuclei in bipolar disorder may thus clarify the nature of the third ventricle enlargement in this condition.
Taken together, these data suggest that mood disorders may be associated with a neuropathological process affecting an anatomical circuit involving the subgenual PFC and related parts of the amygdala, the striatum and the thalamus. If the volumetric abnormalities in the abovementioned structures are related, microscopic inspection of the changes in each structure may nevertheless reflect distinct changes from those identified in the subgenual PFC. For example, if familial mood disorders are associated with a reduction in glia substantial enough to impair glutamate uptake in the subgenual PFC, then neural transmission from this structure to its efferent projection fields may pathologically increase.
14 Since these projections involve excitatory amino acid transmitters, it might be hypothesized that the volume loss in the amygdala, the striatum, and the thalamus may reflect neuronal loss resulting from excitotoxicity.
Comparison with other functional imaging studies
The subgenual PFC was not specifically assessed in earlier PET studies of mood disorders, which generally obtained measures from large preselected regions-ofinterest (ROI) that precluded restricted localization within the very large human PFC. 15 In contrast, more recent PET studies that used statistical mapping or ROI analysis of images of sufficiently high spatial resolution to identify physiological differences in the subgenual PFC have confirmed and extended our neurophysiological finding in depression. Buchsbaum et al 16 Functional imaging studies of depression have identified BF and metabolic abnormalities in a variety of other structures as well in MDD, consistent with the hypothesis that the subgenual PFC participates in an extended functional anatomical network involving multiple structures to mediate the emotional, neuropsychological, neurochemical, and behavioral manifestations of depression. 2, 15 For example, the depressive samples in which we found reduced subgenual PFC glucose metabolism were later shown to also have abnormally increased metabolism in the amygdala, the lateral and posterior orbital cortex, the medial thalamus, and the posterior cingulate cortex, and decreased metabolism in the dorsomedial PFC, the dorsal anterolateral PFC and the caudate. 15 These findings have been consistently reported in previous studies of unmedicated depressives with primary MDD. 15 
Potential implications of subgenual PFC dysfunction
The functional significance of the neuroimaging and microscopic abnormalities in the subgenual PFC in mood disorders is unclear. If a reduction of cortical glia in this area is confirmed, the importance of these cells (eg, astrocytes) in providing trophic factors and energy substrates to neurons, maintaining potassium homeostasis in the extracellular fluid, and removing glutamate from the neuropil to end synaptic transmission suggest mechanisms by which glial hypofunction could disturb synaptic activity within the subgenual PFC.
14 In monkeys and other experimental animals the subgenual PFC has extensive connections with the amygdala, the lateral hypothalamus, the nucleus accumbens, the ventral tegmental area (VTA), the substantia nigra, the raphe, the locus ceruleus, the periaqueductal grey, and brainstem autonomic nuclei. 12, [19] [20] [21] [22] Since these structures have been implicated in various aspects of emotional behavior, it is conceivable that abnormal synaptic interactions involving the projections between these areas and the subgenual PFC may underlie the disturbances of emotional processing, monoaminergic neurotransmitter release, neuroendocrine function, and autonomic regulation seen in depression.
Humans with lesions that include the subgenual PFC demonstrate abnormal autonomic responses to emotional experiences, inability to experience emotion related to concepts that ordinarily evoke emotion, and inability to use information regarding the likelihood of punishment vs reward in guiding social behavior. 23, 24 Based partly upon these observations, Damasio et al 23, 25 proposed that the ability to evaluate the consequences of social behavior depends upon visceral feedback mediated through interactions between the ventromedial PFC, the hypothalamic autonomic centers, and the brainstem monoaminergic neurotransmitter systems. If so, disordered interactions between the subgenual PFC and these latter structures may potentially result in the impairments of evaluative processing seen in mood disorders. For example, such pathological modulation of evaluative processing may conceivably underlie the heightened sensitivity to failure, pathological guilt, and exaggerated self-criticism seen in depression, as well as the swings toward inappropriate elation, emotional lability, and insensitivity to the negative outcome of pleasurable or violent behavior in mania. 7, 26, 27 Compatible with this hypothesis, rats with lesions involving the ventromedial PFC that appear to include the area homologous to the subgenual PFC (ie, approximately prelimbic cortex) demonstrate alterations in neuroendocrine, autonomic and behavioral responses to stress that resemble changes in these systems in humans with mood disorders. 19 For example, Diorio et al 28 showed that medial PFC lesions of the prelimbic and infralimbic portions of the anterior cingulate cortex increased the plasma ACTH and corticosterone (CORT) responses to restraint stress, while implants of crystalline CORT in the same cortical areas decreased the ACTH and CORT responses to restraint stress. Diorio et al 28 concluded that the glucocorticoid receptors demonstrated in these ventromedial PFC areas are involved in the negative feedback effect of glucocorticoids on stress-related hypothalamic-pituitary-adrenal (HPA) axis activity. Since major depression is associated with elevated basal cortisol levels, increased central drive on cortisol release at the circadian nadir, abnormal delayed glucocorticoid negative feedback, and dysregulation of cortisol responses to stressors, the relationship between subgenual PFC dysfunction and HPA axis activity in mood disorders warrants further investigation. 29, 30 In addition to demonstrating neuroendocrine changes, rats with bilateral lesions of the dorsal prelimbic and anterior cingulate cortices also show exaggerated freezing behavior and heart rate increases during exposure to fear-conditioned sensory and/or contextual stimuli. 31, 32 In contrast, bilateral lesions involving both the infralimbic and the ventral prelimbic cortices result in reduced HR responses to fear-conditioned stimuli. 32 Taken together, these findings led Frysztak and Neafsey 32 to propose that the ventral prelimbic and infralimbic cortices normally act to increase heart rate during stress.
This drive on increasing sympathetic autonomic arousal and CORT release in response to stress were more specifically linked to the function of the right ventromedial PFC by Sullivan and Grattan. 33 They reported that rats with lesions involving the left infralimbic, prelimbic, and anterior cingulate cortices demonstrated heightened sympathetic autonomic arousal and exaggerated CORT responses to restraint stress relative both to control animals and to animals with right-sided lesions of the same areas. In contrast, rightlesioned animals showed attenuation of the CORT rise and the autonomically-mediated gastric stress pathology associated with restraint stress. From these data Sullivan and Grattan 33 concluded that left ventromedial PFC lesions disinhibit the function of the right ventromedial PFC, which mediates the heightened sympathetic autonomic, affective, and HPA-axis arousal seen in the left-lesioned animals. (Specialization of functions based upon laterality may also account for the observations that while bilateral lesions of the prelimbic and infralimbic cortices increase the plasma CORT responses to restraint stress, 28 nevertheless electrical stimulation of the prelimbic cortex also increases circulating CORT. 34 Given the left-lateralization of our neuroimaging findings in the subgenual PFC, 1 these lesion analyses suggest the hypothesis that dysfunction of the left subgenual PFC in mood disorders specifically results in the heightened affective, neuroendocrine and sympathetic autonomic arousal seen in depression. 26, 29, 30, 35 Lesions of the ventromedial PFC also alter parasympathetic autonomic function in rats in a manner that shows an intriguing parallel with autonomic abnormalities reported in humans with MDD. Frysztak and Neafsey 32 found that rats with lesions of the prelimbic and infralimbic cortex show reduced beat-to-beat variability of the heart rate both at rest and during exposure to fear-conditioned stimuli. Heart rate variability (HRV) putatively reflects parasympathetic control of the sinus node via vagal nerve transmission. 36, 37 Since the area corresponding to the subgenual PFC contains neurons that project to the nucleus tractus solitarius (NTS) of the vagus nerve, 22 it is possible that ventromedial PFC lesions which disrupt these projections reduce parasympathetic tone, resulting in blunted HRV.
In considering the effects of ventromedial PFC lesions on sympathetic and parasympathetic function in rats, it is noteworthy that depressed humans have been shown to have reduced HRV, elevated resting heart rate, and increased sympathetic nervous system activity relative to controls. 35, 38 The imbalance in sympathetic-to-parasympathetic tone reflected by these autonomic abnormalities is hypothesized to account for the elevated risks for developing ventricular tachycardia, myocardial infarction and sudden death seen in depressed patients with cardiovascular disease. [39] [40] [41] Given the role of the subgenual PFC in modulating autonomic nervous system function, investigations of the relationship between neuroimaging abnormalities in the subgenual PFC and this pattern of reduced parasympathetic and increased sympathetic function in MDD are warranted.
In addition to modulating autonomic and neuroendocrine responses to behaviorally significant stimuli, the subgenual PFC may also participate in evaluative processing via modulation of monoaminergic neurotransmitter function. The midbrain connections of the subgenual PFC include projections to neurons in the VTA, the substantia nigra, the raphe, and the locus ceruleus. [19] [20] [21] 42 Although the functional significance of these anatomical connections remains unclear, the extant data regarding the ventromedial PFC and its relationship to the mesolimbic dopamine (DA) system merit comment.
Of the PFC areas that receive dopaminergic inputs, Area 24 of the anterior cingulate gyrus (part of which is comprised by the subgenual PFC) receives the most dense DA innervation, principally from the VTA. 43 In rats, electrical or glutamatergic stimulation of medial PFC areas that appear to include the subgenual PFC elicits burst firing patterns of dopaminergic cells in the VTA and increases DA release in the nucleus. [44] [45] [46] [47] [48] The burst firing of DA cell activity elicits more terminal DA release per action potential than the non-bursting, pacemaker firing pattern. 46 The phasic, burst firing of DA neurons and accompanying rise in DA release normally occur in response to primary rewards (until they become fully predicted) and reward-predicting stimuli. 49 In contrast, once a fully predicted reward suddenly fails to occur, the DA neurons are depressed in their activity at precisely the time when the reward had previously been expected to occur. Thus DA neurons appear to participate in encoding information regarding the stimuli that predict reward and the deviation between this prediction and the actual occurrence of reward. 49 The evidence that the subgenual PFC may modulate the electrophysiological responses of VTA DA neurons suggests that this cortex also participates in evaluating the reward-related significance of stimuli.
Such a role would provide a neural mechanism by which subgenual PFC dysfunction could alter hedonic perceptions and motivated behavior in mood disorders. The PET imaging evidence that glucose metabolism in the subgenual PFC is abnormally decreased in the depressed but increased in the manic phase of bipolar disorder 1 suggests the following hypothesis. In depression reduced subgenual PFC activity is associa-ted with diminished stimulation of mesolimbic DA release, resulting in the absence of behavioral incentive, apathy and anhedonia, whereas in mania increased subgenual PFC activity results in excessive stimulation of mesolimbic DA release, manifested by exaggerated hedonic responses and press of occupation. 50, 51 This hypothesis is compatible with pharmacological evidence that antidepressant drugs enhance mesolimbic dopamine receptor sensitivity and increase interstitial DA concentrations in the medial PFC, that DA receptor antagonists and DA synthesis inhibitors have antimanic effects, and that mania can be precipitated (in euthymic or depressed bipolar patients) by DA receptor agonists. 50, 52, 53 Potential implications for antidepressant treatment mechanisms Antidepressant treatments produce adaptive changes in other neurotransmitter systems as well which may modulate or compensate for the effects of subgenual PFC dysfunction. For example, chronic administration of ECS and of virtually all antidepressant drugs reduces ligand binding to glutamatergic-NMDA receptors in the frontal cortex (but not in the hippocampus, striatum, or basal forebrain), leading to hypotheses that NMDAreceptor desensitization comprises the final common pathway for antidepressant action. 54, 55 Compatible with such hypotheses, lamotrigine, an anticonvulsant which putatively inhibits glutamate release, was recently shown to be effective in ameliorating treatment-resistant, bipolar depression. 56 Since cortical glia are involved in transporting glutamate away from the synapse, our preliminary finding of reduced glial cell counts in the subgenual PFC suggests a cerebral target where reducing glutamatergic function may counter the pathophysiology of mood disorders.
14 Potentially consistent with the hypothesis that reduced glial function in mood disorders results in inadequate glutamate transport, the proportion of high affinity, glycine-displacable [ 3 H]CGP-39653 binding to NMDA glutamatergic receptors is reportedly reduced in the frontal cortex of suicide victims (possibly because elevated exposure to glutamate resulted in a compensatory shift away from the high affinity state). 57 Antidepressant treatments may thus compensate for reduced glutamate uptake by glia by desensitizing the N-methyl-d-aspartate (NMDA) receptor complex.
Summary
The neuroimaging abnormalities in the subgenual PFC and the possibility that these are accounted for by demonstrable histopathological changes indicate that further research into this region's function and structure in mood disorders is warranted. If the preliminary post mortem data presented herein are confirmed in larger subject samples and shown to be specific to the pathophysiology of mood disorders, elucidating their nature and their anatomical extent may provide clues regarding the etiopathology of familial mood disorders and the mechanisms of antidepressant or antimanic treatments. Finally, while the available analyses of lesions that encompassed the subgenual PFC in rats and humans examined lesions that would have also affected the surrounding cortex, their results nevertheless implicate this region as a site where dysfunction could conceivably result in the emotional, autonomic, neuroendocrine, and behavioral manifestations of depression and mania.
